Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung-MAP Screening Study in Previously-Treated Non-Small Cell Lung Cancer
NCT03851445Phase 3Recruiting
- Sponsor
- SWOG Cancer Research Network
- Start
- Feb 2019
- Primary completion
- Jan 2029
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial in non-small cell lung cancer (NSCLC), sponsored by SWOG Cancer Research Network. Primary endpoints: Screening Success (Tissue Submission) at 3 years, Screening Success (Adequate Tissue) at 3 years and 4 more. Started Feb 2019; status: recruiting.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03851445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03851445.